Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (9)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
H. LOPEZ-PELAYO ; A. BATALLA ; M. M. BALCELLS ; J. COLOM ; A. GUAL |BACKGROUND: Cannabis use and misuse have become a public health problem. There is a need for reliable screening and assessment tools to identify harmful cannabis use at an early stage. We conducted a systematic review of published instruments us[...]
Article : Périodique
H. LOPEZ-PELAYO ; A. COMA ; A. GUAL ; C. ZARA ; A. LLIGONA |OBJECTIVE: Benzodiazepines have a good safety profile. Nevertheless, off-label use of these drugs may increase the risk of falls, dependence, and memory loss. Off-label prescription use is not highly prevalent. Studies have not researched the fa[...]
Article : Périodique
C. CASAJUANA ; H. LOPEZ-PELAYO ; M. M. BALCELLS ; L. MIQUEL ; J. COLOM ; A. GUAL |Although cannabis is widely used, it remains unclear which consumption patterns are more likely to produce future consequences (risky/hazardous use) or current damage (problematic/harmful use). This unresolved issue contributes to cannabis publi[...]
Article : Périodique
H. LOPEZ-PELAYO ; J. VICENTE ; A. GALLEGOS ; A. McAULEY ; Y. BUYUK ; M. WHITE ; I. GIRAUDON |Background-Aims: New psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the drug conventions of the United Nations. In the last 10 years, numerous NPS have been identified in Europe but there is no co[...]Article : Périodique
INTRODUCTION: The Standard Joint Unit (1 SJU = 7 mg of 9-Tetrahydrocannabinol) simplifies the exploration of risky patterns of cannabis use. This study proposes a preliminary quantitative cutoff criterion to screen for cannabis use disorder (CUD[...]
Article : Périodique
H. LOPEZ-PELAYO ; S. MADERO ; L. GREMEAUX ; S. RONKA ; J. MATIAS |The aim of the current study is to assess if the patterns of use, socio-demographic characteristics, and use of other drugs differ among people who only use cannabis and those that use synthetic cannabinoids. Data from the second wave of the Eur[...]![The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]](https://bdoc.ofdt.fr/img_cache/cec0c2a6bd183ee315bab6c021c39c9b.png)
Article : Périodique
V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN |BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]
Article : Périodique
ENGLISH: INTRODUCTION: Systematic screening of problematic cannabis use does not include the motivations that lead to consumption, although from a person-centered perspective this is fundamental. The present study explores the motivations for c[...]
Article : Périodique
C. CASAJUANA KOGEL ; M. M. BALCELLS-OLIVERO ; H. LOPEZ-PELAYO ; L. MIQUEL ; L. TEIXIDO ; J. COLOM ; D. J. NUTT ; J. REHM ; A. GUAL |Objective: Reliable data on cannabis quantities is required to improve assessment of cannabis consumption for epidemiological analysis and clinical assessment, consequently a Standard Joint Unit (SJU) based on quantity of 9-Tetrahydrocannabinol [...]
